4Filing Date: Jul 23, 2026
Vertex (VRTX)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000875320-26-000253
Total Value$0
Trades1
Insiders1
Transaction Details
Tatsis Ourania
EVP, Chief Reg. & Quality Off.·Direct
Grant · Acquire
Common Stock
Shares+8.25K
Price$0.00
Total Value$0
Shares Owned After53.57K
Transaction DateJul 21, 2026
Footnotes ▸
Restricted stock unit award that vests on 03/31/2030.
Post-Transaction Holdings
Tatsis Ourania · EVP, Chief Reg. & Quality Off.
| Security | Shares | Change |
|---|---|---|
| Common Stock | 53.57K | +8.25K (18.21%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-07-21
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
--- Reporting Owner ---
Name: Tatsis Ourania
CIK: 0001789815
Role: Officer (EVP, Chief Reg. & Quality Off.)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-07-21 | Code: A (Grant or award)
Shares: +8,251 | Price: $0.00
Shares Owned After: 53,572 | Ownership: D (Direct)
Footnotes:
[F1] Restricted stock unit award that vests on 03/31/2030.
--- Footnotes (Complete Index) ---
F1: Restricted stock unit award that vests on 03/31/2030.
--- Signature ---
/s/ /s/ Christiana Stevenson, Attorney-in-Fact (2026-07-23)